Related Experiment Videos
Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients
Abstract:
Metabolism of 25-[3H]hydroxyvitamin D3 was studied in peritoneal macrophages from renal failure patients on continuous ambulatory peritoneal dialysis (CAPD). Cells from 5 out of 8 patients with a history of peritonitis produced significant amounts of a metabolite chromatographically identical to 1 alpha,25(OH)2D3; but none was produced by cells from non-infected patients. The evidence strongly suggests that peritoneal macrophages stimulated by infection can metabolise 25OHD3 to the active vitamin D3 metabolite, 1 alpha,25(OH)2D3, when maintained in short-term primary culture.
Insights
Peritoneal macrophages from renal failure patients undergoing continuous ambulatory peritoneal dialysis (CAPD) can convert vitamin D3 into its active form, 1 alpha,25(OH)2D3, but only when stimulated by infection.
Area of Science:
- Biochemistry
- Nephrology
- Immunology
Background:
- Patients with renal failure on continuous ambulatory peritoneal dialysis (CAPD) often experience complications like peritonitis.
- Vitamin D metabolism is crucial for calcium homeostasis and bone health, particularly in patients with chronic kidney disease.
- The role of peritoneal macrophages in vitamin D metabolism during infection in CAPD patients is not well understood.
Purpose of the Study:
- To investigate the capacity of peritoneal macrophages from CAPD patients to metabolize 25-hydroxyvitamin D3 (25OHD3).
- To determine if infection (peritonitis) influences this metabolic activity.
- To identify the specific metabolites produced by these macrophages.
Main Methods:
- Peritoneal macrophages were isolated from renal failure patients undergoing CAPD.
- Cells were incubated with radiolabeled 25-hydroxyvitamin D3 ([3H]25OHD3).
- Metabolites were analyzed using chromatographic methods to identify 1 alpha,25(OH)2D3.
Main Results:
- Macrophages from 5 out of 8 patients with a history of peritonitis produced significant amounts of 1 alpha,25(OH)2D3.
- Macrophages from non-infected patients did not produce detectable levels of 1 alpha,25(OH)2D3.
- The metabolite produced was chromatographically identical to 1 alpha,25(OH)2D3.
Conclusions:
- Peritoneal macrophages from CAPD patients can metabolize 25OHD3 to the active form, 1 alpha,25(OH)2D3.
- This metabolic activity appears to be stimulated by infection (peritonitis).
- Infection may enhance the local production of active vitamin D in the peritoneal cavity of CAPD patients.